First Time Loading...

Huadong Medicine Co Ltd
SZSE:000963

Watchlist Manager
Huadong Medicine Co Ltd Logo
Huadong Medicine Co Ltd
SZSE:000963
Watchlist
Price: 32.94 CNY -0.09% Market Closed
Updated: May 2, 2024
Huadong Medicine Co Ltd
/
Cash Flow Statement
/
Cash from Investing Activities

Huadong Medicine Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Huadong Medicine Co Ltd
Cash from Investing Activities Peer Comparison

Comparables:
1099
S
601607
600998
C
600511
C
000028

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Huadong Medicine Co Ltd
SZSE:000963
Cash from Investing Activities
-¥1.2B
CAGR 3-Years
4%
CAGR 5-Years
13%
CAGR 10-Years
-17%
Sinopharm Group Co Ltd
HKEX:1099
Cash from Investing Activities
-¥2.8B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
1%
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Cash from Investing Activities
-¥2.5B
CAGR 3-Years
-13%
CAGR 5-Years
20%
CAGR 10-Years
-11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Cash from Investing Activities
-¥1.5B
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
-11%
C
China National Medicines Corp Ltd
SSE:600511
Cash from Investing Activities
-¥129.3m
CAGR 3-Years
-32%
CAGR 5-Years
8%
CAGR 10-Years
-1%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Cash from Investing Activities
-¥135.4m
CAGR 3-Years
63%
CAGR 5-Years
9%
CAGR 10-Years
0%

See Also

What is Huadong Medicine Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-1.2B CNY

Based on the financial report for Sep 30, 2023, Huadong Medicine Co Ltd's Cash from Investing Activities amounts to -1.2B CNY.

What is Huadong Medicine Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-17%

Over the last year, the Cash from Investing Activities growth was 57%. The average annual Cash from Investing Activities growth rates for Huadong Medicine Co Ltd have been 4% over the past three years , 13% over the past five years , and -17% over the past ten years .

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.